dihydroxyphenylalanine has been researched along with Hepatitis B in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Criswell, SR | 1 |
| Perlmutter, JS | 1 |
| Crippin, JS | 1 |
| Videen, TO | 1 |
| Moerlein, SM | 1 |
| Flores, HP | 1 |
| Birke, AM | 1 |
| Racette, BA | 1 |
1 other study available for dihydroxyphenylalanine and Hepatitis B
| Article | Year |
|---|---|
Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.
Topics: Caudate Nucleus; Ceruloplasmin; Dihydroxyphenylalanine; End Stage Liver Disease; Hepatitis B; Humans | 2012 |